Results 211 to 220 of about 3,152,690 (357)

Switching Enzyme Replacement Therapy for Late‐Onset Pompe Disease From Alglucosidase Alfa to Cipaglucosidase Alfa Plus Miglustat: Post Hoc Effect Size Analysis of PROPEL

Muscle &Nerve, EarlyView.
A total of 95 ERT‐experienced adults with LOPD were randomized to switch to cipaglucosidase alfa + miglustat or remain on alglucosidase alfa treatment. After 52 weeks, patients remaining on alglucosidase alfa showed worsening or stability for most outcomes, whereas patients who switched to cipaglucosidase alfa + miglustat generally showed stability or ...
Hani Kushlaf, Jordi Díaz‐Manera, Drago Bratkovic, Barry J. Byrne, Kristl G. Claeys, Paula R. Clemens, Mazen M. Dimachkie, Priya S. Kishnani, Pascal Laforêt, Mark Roberts, Benedikt Schoser, Antonio Toscano, Jeff Castelli, Fred Holdbrook, Sheela Sitaraman Das, Mitchell Goldman, Tahseen Mozaffar, on behalf of the PROPEL Study Group   +17 more
wiley   +1 more source

From Mechanisms to Medicine: Neurovascular Coupling in the Diagnosis and Treatment of Cerebrovascular Disorders: A Narrative Review. [PDF]

Cells
Yang L, Zhao W, Kan Y, Ren C, Ji X.
europepmc   +1 more source

Cerebrovascular diseases with special reference to clinical disorders in maintenance dialysis patients.

, 2000
Tsunehiko Noda, Masashi Suzuki, Shigeru Miyazaki, Yoshiji Takaesu, Susumu Haginoshita, Ikuo Aoike, Tai Sakurabayashi, Yutaka Koda, Yasuko Yuasa, Shinji Sakai, Sachio Takahashi, Kazuo Suzuki, Yoshihei Hirasawa   +12 more
openalex   +2 more sources

Add-on quetiapine in the treatment of major depressive disorder in elderly patients with cerebrovascular damage [PDF]

, 2007
Mauro Giovanni Carta, Fausta Zairo, Gisa Mellino, Maria Carolina Hardoy   +3 more
openalex   +1 more source

Mitochondrial transfer as a novel therapeutic approach in ischemic stroke treatment: Current challenges and future perspectives

Neuroprotection, EarlyView.
Cerebral ischemia is a serious neurological disease that mainly leads to pathological changes such as mitochondrial dysfunction, oxidative stress and iron death. Mitochondria play a key role in the regulation of cellular energy metabolism and oxidative stress, and their damage can lead to mitochondrial damage, reduced adenosine triphosphate production,
Shuchen Meng, Min Bai, Changsheng Ma, Bo Han, Mengyuan Duan, Liying Zhang, Jinfen Guo, Changku Shi, Ke Li, Maotao He   +9 more
wiley   +1 more source

Relationship Between Ankylosing Spondylitis and Cerebrovascular Disorders: A Systematic Review. [PDF]

Eurasian J Med
Heidari MM, Khaledi A, Taravati AM, Rastegar-Kashkouli A, Moammer F, Safari I.   +5 more
europepmc   +1 more source

Analysis of Factors Influencing the QOL of Middle-Aged and Elderly People with Cerebrovascular Disorder.

, 2000
Misako Koizumi, Yukie Kamiyama, Emiko Kishi   +2 more
openalex   +2 more sources

Essential Oil Profiles of Lippia turbinata (Verbenaceae) from Argentina: Insights from a Systematic Review and Meta‐Analysis

ChemistryOpen, EarlyView.
This study systematically reviews essential oil (EO) profiles of Lippia turbinata (Verbenaceae) populations from Argentina. A meta‐analysis reveals significant chemical variability and distinct chemotypes, primarily defined by limonene, carvone, β‐caryophyllene, and caryophyllene oxide.
Fernando Livio Corzo, Franco Emmanuel Calvo, Emilio Fernando Lizarraga, Guillermo Emilio Marcial, Maria Ines Mercado   +4 more
wiley   +1 more source

Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of cerebral venous sinus thrombosis. [PDF]

Stroke Vasc Neurol, 2020
Fan Y, Yu J, Chen H, Zhang J, Duan J, Mo D, Zhu W, Wang B, Ouyang F, Chen Y, Lan L, Zeng J, Chinese Stroke Association Stroke Council CVST Guideline Writing Committee.   +12 more
europepmc   +1 more source

Origin, diagnosis and treatment of cardiac and cerebrovascular disorder. Recent advances IV. Treatment 1. Treatment and prognosis of coronary artery disease.

, 2000
延吉 正清
openalex   +2 more sources